Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company dedicated to advancing new cancer therapies based on novel DNA-damage response technologies, is ...
Shares in the sports-bar chain opened at $17.45 on the Nasdaq on Thursday. Proceeds will be used to pay down debt and fuel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback